Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF Withdrawal in Stable SLE
NCT01946880Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in systemic lupus erythematosus (SLE), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2013; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01946880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01946880.